Finance

Lists
MD:NYSE
Pediatrix Medical Group Inc
USD 27,54
+0,88%
(+0,24) 1D
20 Okt., 10:07:46 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MD...
Open
USD 27,60
High
USD 27,74
Low
USD 27,30
Mkt. cap
2,24 mjd
Avg. vol.
726,32 k
Volume
22,78 k
P/E ratio
13,23
52-wk high
USD 28,02
52-wk low
USD 16,82
EPS
USD 2,08
Beta
0,61
Shares outstanding
81,25 m
No. of employees
4 k
Open
USD 27,60
High
USD 27,74
Low
USD 27,30
Mkt. cap
2,24 mjd
Avg. vol.
726,32 k
Volume
22,78 k
P/E ratio
13,23
52-wk high
USD 28,02
52-wk low
USD 16,82
EPS
USD 2,08
Beta
0,61
Shares outstanding
81,25 m
No. of employees
4 k
News stories
From web sources and news partners
About Pediatrix Medical Group Inc
CEOJames D. Swift
Employees4,28 k
Founded2007
Headquarters-
SectorHealth care provider
Websitepediatrix.com
Analyst ratings
Based on 6 analysts giving stock ratings to MD in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MD in the last 3 months.
Highest
Current USD 27,54
USD 28,00 (+1,67%)
Average
USD 27,40 (-0,51%)
Lowest
USD 25,00 (-9,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jack Slevin
Jefferies
Hold
Downgraded
USD 28,00
+1,7%
08/19/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
USD 28,00
+1,7%
08/11/2026
A.J. Rice
UBS
Hold
Maintained
USD 28,00
+1,7%
08/06/2026
David S Macdonald
Truist Financial
Hold
Maintained
USD 28,00
+1,7%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
USD 25,00
-9,2%
08/05/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/04/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
-
-
02/20/2026
Next call oor 9 dae
Do. 29 Okt., 15:00
Fiscal period
Q3 2026
- / USD 0,65
Revenue / Est. (USD)
- / 498,18 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
492,88 m
493,77 m
476,20 m
487,78 m
Cost of goods sold
352,53 m
367,79 m
363,23 m
355,31 m
Cost of revenue
352,53 m
367,79 m
363,23 m
355,31 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,79 m
65,68 m
60,27 m
61,29 m
Operating expense
66,34 m
71,31 m
66,38 m
67,07 m
Total operating expenses
418,87 m
439,10 m
429,62 m
422,39 m
Operating income
74,00 m
54,67 m
46,58 m
65,40 m
Other non operating income
-
-
-
-
EBT including unusual items
87,78 m
45,60 m
38,84 m
54,00 m
EBT excluding unusual items
72,83 m
51,47 m
43,77 m
62,48 m
Income tax expense
16,07 m
11,91 m
9,27 m
14,16 m
Effective tax rate
18,31%
26,13%
23,87%
26,22%
Other operating expenses
-
-
-
-
Net income
71,71 m
33,68 m
29,57 m
39,84 m
Net profit margin
14,55%
6,82%
6,21%
8,17%
Earnings per share
0,67
0,50
0,44
0,63
Interest and investment income
5,88 m
4,70 m
4,76 m
4,55 m
Interest expense
-8,94 m
-8,74 m
-8,26 m
-8,17 m
Net interest expenses
-3,06 m
-4,04 m
-3,50 m
-3,62 m
Depreciation and amortization charges
5,55 m
5,63 m
6,12 m
5,78 m
EBITDA
79,56 m
60,30 m
52,70 m
71,18 m
Gain or loss from assets sale
-20,91 m
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme